OM-89 [Uro-Vaxom® Capsule] Clinical Trials
2 recruitingDrug
Phase 41Phase 31
Showing 1–2 of 2 trials
Recruiting
Phase 3
Assess the Efficacy of OM-89 vs Placebo in Reducing Antibiotic Consumption Associated With the Treatment of Urinary Tract Infections in Patients With Neurogenic Bladder
Neurogenic Bladder
Centre Hospitalier Universitaire Dijon110 enrolled1 locationNCT06588010
Recruiting
Phase 4
The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome
Chronic Pelvic Pain SyndromeChronic ProstatitisChronic Prostatitis With Chronic Pelvic Pain Syndrome
AJU Pharm Co., Ltd.332 enrolled1 locationNCT06345014